David Kaslow, M.D. has announced plans to leave his job as chief scientific officer at Vical. He is returning to Merck & Co. Vical says it does not plan to replace Dr. Kaslow.
Neurologix has named John Mordock to the post of chief executive officer. Mordock, a partner of Red Bird Capital, is replacing Michael Sorell.
MonoSolRx announced the hiring of Keith J. Kendall as its new senior vice president and chief financial officer.
Ray "Rui" Zhong has joined China Biopharmaceuticals as senior vice president, finance and business development.
VaxGen announced that Kathrin U. Jansen, Ph.D., the company's senior vice president, research and development and chief scientific officer, has accepted the position of senior vice president of vaccine research at Wyeth, and has resigned from VaxGen.
Antigenics announced that Shalini Sharp, currently senior director of strategic planning and corporate development, will be appointed as the company's chief financial officer and vice president as of September 30. Peter Thornton plans to return to Ireland with his family.
Immtech Pharmaceuticals has named Carol Ann Olson, M.D., Ph.D., senior vice president of pharmaceutical development and chief medical officer.
Poniard Pharmaceuticals has appointed Alan B. Glassberg, M.D., as chief medical officer.
Exagen Diagnostics has named Luc Van Hove, M.D., PhD, CSSBB, as vice president, quality, regulatory, medical affairs and chief medical officer.
Halozyme Therapeutics has named Robert Little vice president and chief commercial officer.
Novo Nordisk, has appointed Howard Levy, M.D., Ph.D., executive director of clinical research-hemostasis in the company's clinical development, medical, and regulatory affairs department. The company also named Henry Cortina associate vice president of information technology in the United States.
EntreMed has named the following people to its new scientific advisory board: Tak W. Mak, S. Gail Eckhardt, M.D., Michael E. Weinblatt, M.D., Hans Wigzell, M.D., Ph.D.
Phytopharm plc has appointed Peter Robin Blower, M.D., former director of new neuroscience products at SmithKline Beecham, as a non-executive board director of Phytopharm.
Portola Pharmaceuticals has appointed Peggy V. Phillips, former chief operating officer at Immunex, to the company's board of directors.
Jerome Groopman, M.D., has submitted his resignation from Genta's board of directors due to personal health reasons.
Magellan Biosciences has named Michael E. Woehler, Ph.D., to the company's board of directors.
Clarient has named Dennis Morgan Smith Jr., M.D., as member of the board and James A. Datin to chairman of the board of directors.
Zelos Therapeutics has added Colin Goddard, Ph.D., to its board of directors.
Argolyn Bioscience announced that James R. McNab, Jr. has been appointed to the position of executive chairman of the board of directors.
MGI PHARMA has named James O. Armitage, M.D., F.A.C.P., F.R.C.P., to its board.